1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE
Star0
Identification
- Generic Name
- 1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE
- DrugBank Accession Number
- DB04685
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 472.5075
Monoisotopic: 472.179835503 - Chemical Formula
- C28H25FN2O4
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UDeoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial Not Available Humans UDeoxyuridine 5'-triphosphate nucleotidohydrolase, putative Not Available Plasmodium falciparum (isolate 3D7) - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as triphenyl compounds. These are aromatic compounds containing a triphenyl moiety.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Triphenyl compounds
- Sub Class
- Not Available
- Direct Parent
- Triphenyl compounds
- Alternative Parents
- Pyrimidine 2',3'-dideoxyribonucleosides / Benzylethers / Pyrimidones / Hydropyrimidines / Vinylogous amides / Heteroaromatic compounds / Tetrahydrofurans / Lactams / Ureas / Azacyclic compounds show 8 more
- Substituents
- Alkyl fluoride / Alkyl halide / Aromatic heteromonocyclic compound / Azacycle / Benzylether / Dialkyl ether / Ether / Heteroaromatic compound / Hydrocarbon derivative / Hydropyrimidine show 20 more
- Molecular Framework
- Aromatic heteromonocyclic compounds
- External Descriptors
- organofluorine compound, pyrimidine 2',3'-dideoxyribonucleoside (CHEBI:42311)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- GJNIPWYJQUGERM-BFLUCZKCSA-N
- InChI
- InChI=1S/C28H25FN2O4/c29-23-18-26(31-17-16-25(32)30-27(31)33)35-24(23)19-34-28(20-10-4-1-5-11-20,21-12-6-2-7-13-21)22-14-8-3-9-15-22/h1-17,23-24,26H,18-19H2,(H,30,32,33)/t23-,24+,26+/m0/s1
- IUPAC Name
- 1-[(2R,4S,5R)-4-fluoro-5-[(triphenylmethoxy)methyl]oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
- SMILES
- [H][C@]1(F)C[C@@]([H])(O[C@]1([H])COC(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1)N1C=CC(=O)NC1=O
References
- General References
- Not Available
- External Links
- PubChem Compound
- 4369390
- PubChem Substance
- 46507952
- ChemSpider
- 3571965
- BindingDB
- 50190544
- ChEMBL
- CHEMBL209720
- ZINC
- ZINC000012504465
- PDBe Ligand
- DUX
- PDB Entries
- 1vyq
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.00117 mg/mL ALOGPS logP 4.3 ALOGPS logP 5.18 Chemaxon logS -5.6 ALOGPS pKa (Strongest Acidic) 9.86 Chemaxon pKa (Strongest Basic) -4 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 67.87 Å2 Chemaxon Rotatable Bond Count 7 Chemaxon Refractivity 129.16 m3·mol-1 Chemaxon Polarizability 48.78 Å3 Chemaxon Number of Rings 5 Chemaxon Bioavailability 1 Chemaxon Rule of Five No Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9848 Blood Brain Barrier + 0.9766 Caco-2 permeable - 0.7197 P-glycoprotein substrate Non-substrate 0.6847 P-glycoprotein inhibitor I Inhibitor 0.6644 P-glycoprotein inhibitor II Inhibitor 0.577 Renal organic cation transporter Non-inhibitor 0.7149 CYP450 2C9 substrate Non-substrate 0.7997 CYP450 2D6 substrate Non-substrate 0.8646 CYP450 3A4 substrate Substrate 0.6115 CYP450 1A2 substrate Non-inhibitor 0.7767 CYP450 2C9 inhibitor Inhibitor 0.5645 CYP450 2D6 inhibitor Non-inhibitor 0.8685 CYP450 2C19 inhibitor Inhibitor 0.5426 CYP450 3A4 inhibitor Inhibitor 0.5271 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.7171 Ames test Non AMES toxic 0.5222 Carcinogenicity Non-carcinogens 0.7734 Biodegradation Not ready biodegradable 1.0 Rat acute toxicity 2.4522 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9611 hERG inhibition (predictor II) Non-inhibitor 0.6032
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Poly(a) rna binding
- Specific Function
- This enzyme is involved in nucleotide metabolism: it produces dUMP, the immediate precursor of thymidine nucleotides and it decreases the intracellular concentration of dUTP so that uracil cannot b...
- Gene Name
- DUT
- Uniprot ID
- P33316
- Uniprot Name
- Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial
- Molecular Weight
- 26562.975 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
- Kind
- Protein
- Organism
- Plasmodium falciparum (isolate 3D7)
- Pharmacological action
- Unknown
- General Function
- Dutp diphosphatase activity
- Specific Function
- Not Available
- Gene Name
- Not Available
- Uniprot ID
- Q8II92
- Uniprot Name
- Deoxyuridine 5'-triphosphate nucleotidohydrolase, putative
- Molecular Weight
- 19572.98 Da
Drug created at September 11, 2007 17:49 / Updated at June 12, 2020 16:52